Impact of the Use of Ketamine in Laparoscopic Surgery.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03724019 |
|
Recruitment Status :
Recruiting
First Posted : October 30, 2018
Last Update Posted : November 2, 2018
|
Sponsor:
Universidade do Porto
Information provided by (Responsible Party):
Universidade do Porto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
In order to improve the postoperative period (namely pain control), several drugs can be used. For instance, ketamine is a general anesthetic that holds strong analgesic properties, yet also owns undesirable effects, in which hallucination phenomena is one the most common indicator. However, slight information is available about the real implication in the quality of the recovery on the use of ketamine for postoperative pain treatment. The quality of the recovery includes several health conditions, such as pain, physical comfort, physical independence, psychological support and emotional state. In recent years, investigations in this field has been attracted the attention by the health professionals, since is an indicator of the quality of post-operative care. To evaluate these parameters, questionnaires have been developed, in which the Portuguese version of Quality of Recovery 15 (QoR-15) is include. This questionnaire evaluates five psychometric dimensions. Therefore, the present study has the main goal, the evaluation of the effect of using ketamine in laparoscopic surgery and the quality of the recovery using the QoR-15 questionnaire.
| Condition or disease | Intervention/treatment |
|---|---|
| Quality of Recovery | Drug: Ketamine |
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 80 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 2 Days |
| Official Title: | Evaluation of the Impact of the Use of Ketamine in Laparoscopic Surgery, Using the Quality of Recovery 15 Questionnaire. |
| Actual Study Start Date : | October 1, 2018 |
| Estimated Primary Completion Date : | January 1, 2019 |
| Estimated Study Completion Date : | December 1, 2019 |
Resource links provided by the National Library of Medicine
Drug Information available for:
Ketamine
| Group/Cohort | Intervention/treatment |
|---|---|
|
Group Q
20 milliliter of ketamine (0.5mg / kg ideal body weight) at induction of anesthesia.
|
Drug: Ketamine
Administration of 0.5mg / kg ideal body weight of ketamine at induction of anesthesia in laparoscopic surgery. |
|
Group S
20 milliliter of sodium chloride at induction of anesthesia.
|
Primary Outcome Measures :
- Impact in QoR-15 score [ Time Frame: 6 months ]Difference (improvement or worsening) in the postoperative baseline score (preoperative) in the Portuguese version of the Quality of Recovery questionnaire 15.
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Probability Sample |
Study Population
Patients submitted to laparoscopic surgery at the Hospital Center of São João (Oporto / Portugal) in General Surgery (abdominal surgery), Urology (Nephrectomy) or Gynecology (Hysterectomy) and admitted to the PACU.
Criteria
Inclusion Criteria:
- Patients between 18 and 65 years age, with an American Society of Anesthesiology physical status I or II.
Exclusion Criteria:
- drug abusers (current or past history) or alcohol abuse, medication with benzodiazepines, inability to give informed consent, pregnant, emergency surgery, psychiatric pathology, existence of surgical complications in the recovery and admission to a level II or III unit ( for any reason).
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03724019
Locations
| Portugal | |
| CHU São João | Recruiting |
| Porto, Portugal, 4200 | |
| Contact: Helder Pereira +351225512100 u008909@chsj.min-saude.pt | |
Sponsors and Collaborators
Universidade do Porto
Additional Information:
| Responsible Party: | Universidade do Porto |
| ClinicalTrials.gov Identifier: | NCT03724019 History of Changes |
| Other Study ID Numbers: |
QuetaminaQOR15 |
| First Posted: | October 30, 2018 Key Record Dates |
| Last Update Posted: | November 2, 2018 |
| Last Verified: | September 2018 |
| Studies a U.S. FDA-regulated Drug Product: | Yes |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
Keywords provided by Universidade do Porto:
|
Ketamine QoR-15 Laparoscopic surgery |
Additional relevant MeSH terms:
|
Ketamine Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |
Anesthetics, Dissociative Anesthetics, Intravenous Anesthetics, General Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |